ID   OS 99-1
AC   CVCL_F502
SY   OS99-1
DR   Wikidata; Q54936533
RX   PubMed=18247100;
RX   PubMed=20309879;
CC   Population: African American.
CC   Doubling time: ~16 hours (PubMed=18247100).
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
RX   PubMed=18247100; DOI=10.1007/s11626-007-9075-8;
RA   Gillette, Jennifer Marie
RA   Gibbs, C. Parker
RA   Nielsen-Preiss, Sheila M.
RT   "Establishment and characterization of OS 99-1, a cell line derived
RT   from a highly aggressive primary human osteosarcoma.";
RL   In Vitro Cell. Dev. Biol. Anim. 44:87-95(2008).
//
RX   PubMed=20309879; DOI=10.1002/ijc.25331;
RA   Wang, Lin
RA   Park, Paul
RA   Zhang, Hui-Na
RA   La Marca, Frank
RA   Lin, Chia-Ying
RT   "Prospective identification of tumorigenic osteosarcoma cancer stem
RT   cells in OS99-1 cells based on high aldehyde dehydrogenase activity.";
RL   Int. J. Cancer 128:294-303(2011).
//